Pharmacology of Mood Disorders

Pharmacology of Mood Disorders

September 2005 – Vol 7 – No. 3

State of the art

The pharmacological management of depression
David J. Kupfer, MD

Basic research

The possible contribution of neuronal nicotinic acetylcholine receptors in depression
Daniel Bertrand, PhD

Ethology and the biological correlates of mood
Boris Cyrulnik, MD

Pharmacological aspects

Pharmacogenomics in depression and antidepressants
Brigitta Bondy, MD

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants
Pierre Baumann, PhD; Sven Ulrich, PhD; Gabriel Eckermann, MD; Manfred Gerlach, PhD; Hans-Joachim Kuss, PhD; Gerd Laux, MD; Bruno Müller-Oerlinghausen, MD; Marie Luise Rao, PhD; Peter Riederer, PhD; Gerald Zernig, MD; Christoph Hiemke, PhD

Clinical research

Dose-response relationship of recent antidepressants in the short-term treatment of depression
Patricia Berney, MD

Antidepressants and psychotherapy: a clinical research review
Ellen Frank, PhD; Danielle Novick, BA; David J. Kupfer, MD

Neuroendocrine predictors of the evolution of depression
Fabrice Duval, MD; Marie-Claude Mokrani, PhD; Jose Antonio Monreal Ortiz, MD; Pierre Schulz, MD; Christiane Champeval, PhD; Jean-Paul Macher, MD